Adjuvant Zoledronic Acid Reduces Breast Cancer Deaths

feeds has 409 videos Subscribe Here

Description: Adding zoledronic acid to adjuvant endocrine therapy significantly improved disease-free and overall survival in premenopausal women with endocrine-receptor--positive early breast cancer at 7 years' follow-up in the Austrian Breast and Colorectal Cancer Study Group-12 trial. Dr. Michael Gnant describes the results in this interview at the San Antonio Breast Cancer Symposium.
Shared By : feeds
Posted on : 12/15/11
Added : 6 years ago
Category : Colorectal Cancer

More From feeds

Nothing found.